Evidence map›Paper›PMID 38950951›Full record

ArticleThe Journal of rheumatology2024

Validation of Different Dementia Code-Based Definitions in a Population-Based Study of Rheumatoid Arthritis.

Maria Vassilaki, Roslin Jose George, Rakesh Kumar, Edward Lovering, Sara J Achenbach, Suzette J Bielinski, Jennifer St Sauver, John M Davis, Cynthia S Crowson, Elena Myasoedova

Abstract readValidation Study
In one paragraph

Article in The Journal of rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria VassilakiM. Vassilaki, MD, PhD, S.J. Bielinski, PhD, MEd, J. St. Sauver, PhD, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic; vassilaki.maria@mayo.edu.ORCID 0000-0001-8328-136X
Roslin Jose GeorgeR.J. George, MBBS, MPH, R. Kumar, MBBS, MD, E. Lovering, MBChB, J.M. Davis III, MD, MS, Division of Rheumatology, Department of Internal Medicine, Mayo Clinic.ORCID 0009-0000-2697-3511
Rakesh KumarR.J. George, MBBS, MPH, R. Kumar, MBBS, MD, E. Lovering, MBChB, J.M. Davis III, MD, MS, Division of Rheumatology, Department of Internal Medicine, Mayo Clinic.ORCID 0000-0002-3916-9263
Edward LoveringR.J. George, MBBS, MPH, R. Kumar, MBBS, MD, E. Lovering, MBChB, J.M. Davis III, MD, MS, Division of Rheumatology, Department of Internal Medicine, Mayo Clinic.ORCID 0009-0002-7869-2716
Sara J AchenbachS.J. Achenbach, MS, Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic.
Suzette J BielinskiM. Vassilaki, MD, PhD, S.J. Bielinski, PhD, MEd, J. St. Sauver, PhD, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic.ORCID 0000-0002-2905-5430
Jennifer St SauverM. Vassilaki, MD, PhD, S.J. Bielinski, PhD, MEd, J. St. Sauver, PhD, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic.ORCID 0000-0002-9789-8544
John M DavisR.J. George, MBBS, MPH, R. Kumar, MBBS, MD, E. Lovering, MBChB, J.M. Davis III, MD, MS, Division of Rheumatology, Department of Internal Medicine, Mayo Clinic.ORCID 0000-0002-9710-8143
Cynthia S CrowsonC.S. Crowson, PhD, Division of Rheumatology, Department of Internal Medicine, and Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic.ORCID 0000-0001-5847-7475
Elena MyasoedovaE. Myasoedova, MD, PhD, Division of Rheumatology, Department of Internal Medicine, and Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2006-1436

Funding

HEART DISEASE IN RHEUMATOID ARTHRITISR01AR046849 · NIAMS · MAYO CLINIC ROCHESTER · PI CROWSON, CYNTHIA S · 2000 to 2022
$11.3M
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a PrototypeR01AG068192 · NIA · MAYO CLINIC ROCHESTER · PI Elena Myasoedova · 2020 to 2026
$4.4M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Temporal associations between systemic inflammation, cardiovascular risk profile and development of Alzheimer’s disease and related dementias in patients with rheumatoid arthritisK24AG078179 · NIA · MAYO CLINIC ROCHESTER · PI Elena Myasoedova · 2022 to 2026
$951k
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR21AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2018 to 2019
$437k
Population-Based Outcomes Research for Rheumatoid Arthritis: Rural Health DisparitiesR56AR046849 · NIAMS · MAYO CLINIC ROCHESTER · PI CROWSON, CYNTHIA S · 2023 to 2023
$150k
NIAMS NIH HHS R01 AR046849NIAMS NIH HHS R56 AR046849NIA NIH HHS K24 AG078179NIA NIH HHS R01 AG068192NIA NIH HHS R21 AG058738NIA NIH HHS R33 AG058738
6 · The paper itself

Abstract

objectiveRheumatoid arthritis (RA) has been associated with an elevated dementia risk. This study aimed to examine how different diagnostic dementia definitions perform in patients with RA compared to individuals without RA.

methodsThe study population included 2050 individuals (1025 with RA) from a retrospective, population-based cohort in southern Minnesota and compared the performance of 3 code-based dementia diagnostic algorithms with medical record review diagnosis of dementia. For the overall comparison, each patient's complete medical history was used, with no time frames. Sensitivity analyses were performed using 1-, 2-, and 5-year windows around the date that dementia was identified in the medical record (reference standard).

resultsAlgorithms performed very similarly in persons with and without RA. The algorithms generally had high specificity, negative predictive values, and accuracy, regardless of the time window studied (> 88%). Sensitivity and positive predictive values varied depending on the algorithm and the time window. Sensitivity values ranged 56.5-95.9%, and positive predictive values ranged 55.2-83.1%. Performance measures declined with more restrictive time windows.

conclusionRoutinely collected electronic health record (EHR) data were used to define code-based dementia diagnostic algorithms with good performance (vs diagnosis by medical record review). These results can inform future studies that use retrospective databases, especially in the same or a similar EHR infrastructure, to identify dementia in individuals with RA.

Indexed as

AlgorithmsArthritis, RheumatoidDementiaAgedAged, 80 and overElectronic Health RecordsFemaleHumansMaleMiddle AgedMinnesotaRetrospective StudiesSensitivity and Specificitycode-baseddementiaICD-10ICD-9rheumatoid arthritis

Identifiers

PMID38950951
PMCPMC11444897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.